Estimating the cost of type 1 diabetes in the U.S.: a propensity score matching method.

Estimating the cost of type 1 diabetes in the U.S.: a propensity score matching method.
复制标题

DOI:
10.1371/journal.pone.0011501
复制
发表时间:
2010-07-09
期刊:
影响因子:
3.7
通讯作者:
Taylor D
Taylor D
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Tao B;Pietropaolo M;Atkinson M;Schatz D;Taylor D

文献摘要

参考文献

被引文献

相似文献

Diabetes costs represent a large burden to both patients and the health care system. However, few studies that examine the economic consequences of diabetes have distinguished between the two major forms, type 1 and type 2 diabetes, despite differences in underlying pathologies. Combining the two diseases implies that there is no difference between the costs of type 1 and type 2 diabetes to a patient. In this study, we examine the costs of type 1 diabetes, which is often overlooked due to the larger population of type 2 patients, and compare them to the estimated costs of diabetes reported in the literature. Using a nationally representative dataset, we estimate yearly and lifetime medical and indirect costs of type 1 diabetes by implementing a matching method to compare a patient with type 1 diabetes to a similar individual without the disease. We find that each year type 1 diabetes costs this country $14.4 billion (11.5–17.3) in medical costs and lost income. In terms of lost income, type 1 patients incur a disproportionate share of type 1 and type 2 costs. Further, if the disease were eliminated by therapeutic intervention, an estimated $10.6 billion (7.2–14.0) incurred by a new cohort and $422.9 billion (327.2–519.4) incurred by the existing number of type 1 diabetic patients over their lifetime would be avoided. We find that the costs attributed to type 1 diabetes are disproportionately higher than the number of type 1 patients compared with type 2 patients, suggesting that combining the two diseases when estimating costs is not appropriate. This study and another recent contribution provides a necessary first step in estimating the substantial costs of type 1 diabetes on the U.S.
DOI: 10.1542/peds.109.3.479
发表时间: 2002-03-01
期刊: PEDIATRICS
影响因子: 8
作者:
DiLiberti, JH;Carver, K;McCormick, K
通讯作者: McCormick, K
DOI: 10.1089/pop.2009.12203
发表时间: 2009-04-01
影响因子: 2.5
作者:
Dall, Timothy M.;Mann, Sarah Edge;Zhang, Shiping
通讯作者: Zhang, Shiping
DOI: 10.1111/j.1464-5491.2006.01925.x
发表时间: 2006-08-01
期刊: DIABETIC MEDICINE
影响因子: 3.5
作者:
Bessaoud, K.;Boudraa, G.;Lanes, R.
通讯作者: Lanes, R.
DOI: 10.1111/j.1524-4733.2006.00130.x
发表时间: 2006-11-01
期刊: VALUE IN HEALTH
影响因子: 4.5
作者:
Baser, Onur
通讯作者: Baser, Onur
DOI: 10.2337/diacare.21.7.1138
发表时间: 1998-07-01
期刊: DIABETES CARE
影响因子: 16.2
作者:
Gu, K;Cowie, CC;Harris, MI
通讯作者: Harris, MI